Literature DB >> 17200634

SSRIs and the syndrome of inappropriate antidiuretic hormone secretion.

Carole Noelle Rottmann1.   

Abstract

Selective serotonin reuptake inhibitors, which include some of the mostly widely prescribed drugs in the United States, produce fewer adverse effects than other types of antidepressants. But their use can be associated with disruption of the action of antidiuretic hormone in the body, which wreaks havoc with homeostasis. This may lead to the syndrome of inappropriate antidiuretic hormone secretion (SIADH), which is characterized by hyponatremia, a potentially fatal condition that is typically asymptomatic until it becomes severe. SIADH is more likely in some populations, including people who are elderly or who take diuretics. Serum sodium levels should be monitored closely in those at higher risk.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200634     DOI: 10.1097/00000446-200701000-00022

Source DB:  PubMed          Journal:  Am J Nurs        ISSN: 0002-936X            Impact factor:   2.220


  6 in total

1.  A rare case of fatal hyponatremia due to a combination of psychotropic polypharmacy and hypothyroidism.

Authors:  Chaitanya K Musham; Archana Jarathi; Gabriel Pedraza
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 2.  Management Strategies for Nocturia.

Authors:  Danielle J Gordon; Curran J Emeruwa; Jeffrey P Weiss
Journal:  Curr Urol Rep       Date:  2019-11-09       Impact factor: 3.092

3.  Hyponatremia associated with bupropion.

Authors:  Chang Seong Kim; Joon Seok Choi; Eun Hui Bae; Soo Wan Kim
Journal:  Electrolyte Blood Press       Date:  2011-06-30

4.  Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure.

Authors:  Ciro Costagliola; Francesco Parmeggiani; Francesco Semeraro; Adolfo Sebastiani
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

5.  Bupropion Induced Hyponatremia in an Elderly Patient: A Case Report and Review of the Literature.

Authors:  Sahil Munjal; Yvette Smolin
Journal:  Case Rep Psychiatry       Date:  2016-06-28

Review 6.  Potential Pharmacokinetic Drug-Drug Interactions between Cannabinoids and Drugs Used for Chronic Pain.

Authors:  Marta Vázquez; Natalia Guevara; Cecilia Maldonado; Paulo Cáceres Guido; Paula Schaiquevich
Journal:  Biomed Res Int       Date:  2020-08-13       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.